L. Howard (London, United Kingdom), M.M. Hoeper (Hanover, Germany)
LATE-BREAKING ABSTRACT: Accuracy of transpulmonary thermodilution cardiac output measurement (PiCCO) in patients with right heart failure (RHF) due to precapillary pulmonary hypertension (PH)
E. Artaud-Macari, M. Gilbert, R. Persichini, R. Rifai, S. Gunther, X. Jais, D. Montani, P. Assayag, M. Humbert, G. Simonneau, O. Sitbon, L. Savale (Le Kremlin Bicêtre, France)
|  |
Pulmonary pathological findings in autopsies of sickle cell disease in Brazil
G. Rasse, G. Hencklain, S. Menosi, V. Demarchi, R. Souza, T. Mauad (São Paulo, Brazil; Puerto Montt, Chile)
| |
Load-independent right ventricular function and idiopathic pulmonary arterial hypertension severity
P. Trip, S. Rain, H. J. Bogaard, N. Westerhof, J. van der Velden, F. S. de Man, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
Pulmonary arterial hypertension in patients treated with interferon
L. Savale, S. Gunther, M. C. Chaumais, X. Jais, C. Sattler, E. Artaud Macari, D. Montani, G. Simonneau, M. Humbert, O. Sitbon (Le Kremlin Bicêtre, Clamart, France)
| |
A comparative histological study of pulmonary vascular lesions in lungs of patients With idiopathic or heritable PAH
M. R. Ghigna, C. Guignabert, M. Humbert, P. Dorfmuller (Le Plessis Robinson, Le Kremlin Bicetre, France)
|  |
Pulmonary hypertension (PH) in chronic hemodialysis (CHD) patients is associated with inflammatory markers and volume overload
H. Bok Yoo, L. Cuadrado Martin, R. dos Reis, W. Telini, L. Rodrigues-Telini, J. C. Hueb, P. Barretti, T. Thomaz Queluz (Botucatu, Brazil)
| |
Intracellular accumulation and effects on bile acid transport of endothelin receptor antagonists in sandwich-cultured hepatocytes
H. Gillies, I. Lepist, W. Smith, J. Hao, C. Perry, R. St Claire, K. Brouwer, A. Ray (Foster City, Durham, United States Of America)
| |
Characteristics of idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (APAH-CTD) patients in PROSPECT
H. Farber, R. Frantz, R. Schilz, M. Chakinala, B. Hartline, D. Miller, D. Rosenberg, W. Benton, R. Barst (Boston, Rochester, Cleveland, St. Louis, South San Francisco, San Francisco, New York, United States Of America; Allschwil, Swaziland)
| |
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
H. Kiyokawa, S. Sato, M. Kato, S. Muro, T. Hirai, M. Mishima (Kyoto, Kishiwada, Japan)
| |
Exercise right heart catheterisation in the diagnosis of pulmonary hypertension
S. Keusch, S. Mueller-Mottet, A. Bucher, L. C. Huber, R. Speich, S. Ulrich (Zurich, Switzerland)
| |
Characteristics and outcome of patients with pre-capillary pulmonary hypertension who were drained for tamponade: A monocentric study
E. Artaud-Macari, D. Montani, O. Mercier, R. Persichini, S. Gunther, X. Jais, F. Parent, M. Humbert, G. Simonneau, O. Sitbon, L. Savale (Le Kremlin Bicêtre, Le Plessis Robinson, France)
| |
Explorative breath analysis study for the detection and classification of PAH
S. Cohen-Kaminsky, M. Nakhleh, F. Perros, D. Montani, B. Girerd, G. Garcia, G. Simonneau, H. Haick, M. Humbert (Le Plessis Robinson, Le Kremlin Bicêtre, France; Haiffa, Israel)
| |
Gender differences in right-ventricular arterial coupling in idiopathic pulmonary arterial hypertension
P. Trip, F. S. de Man, H. J. Bogaard, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
Acute vasodilator response in different forms of pre-capillary pulmonary hypertension
M. Coronel, I. Blanco, V. Amado, R. Del Pozo, N. Gonzalez, G. Argemi, J. A. Barberà (Barcelona, Spain)
| |
Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics
L. Huber, S. Ulrich, M. Gassmann, U. Treder, R. Speich, M. Brock (Zurich, Switzerland)
| |
Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN
M. Delcroix, R. Channick, N. Galiè, H. A. Ghofrani, P. Jansa, F. O. Le Brun, S. Mehta, L. Perchenet, T. Pulido, B. K. S. Sastry, O. Sitbon, R. Souza, A. Torbicki, G. Simonneau, L. Rubin (Leuven, Belgium; Boston, San Diego, United States Of America; Bologna, Italy; Giessen, Germany; Prague, Czech Republic; Allschwil, Switzerland; London, Canada; Mexico City, Mexico; Hyderabad, India; Le Kremlin Bicêtre, France; São Paulo, Brazil; ECZ-Otwock, Poland)
| |
Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
H. A. Ghofrani, F. Grimminger, M. M. Hoeper, N. H. Kim, E. Mayer, G. Simonneau, M. Sikirica, A. Fritsch, N. Davie, B. Luong, M. R. Wilkins (Giessen, Hannover, Bad Nauheim, Berlin, Wuppertal, Germany; San Diego, United States Of America; Le Kremlin-Bicêtre, France; London, United Kingdom)
| |
Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
H. A. Ghofrani, N. Galiè, F. Grimminger, M. Humbert, A. M. Keogh, L. J. Rubin, M. Sikirica, A. Fritsch, N. Davie, S. Hudgens, N. Bonner, B. Luong, D. Langleben (Giessen, Berlin, Wuppertal, Germany; Bologna, Italy; Le Kremlin-Bicêtre, France; Sydney, Australia; La Jolla, Boston, United States Of America; Bollington, United Kingdom; Montreal, Canada)
| |